Quantitative Accuracy in Molecular Imaging for Personalized Patient Care

Baltimore, Maryland – June 8, 2015 – Today at the Society for Nuclear Medicine and Molecular Imaging (SNMMI), GE Healthcare is showcasing hybrid molecular imaging, magnetic resonance and nuclear medicine, systems aimed at: lowering dose; enhancing image quality to boost clinical confidence; and helping clinicians deliver more efficient, personalized care to increase diagnostic accuracy. GE... Read more

GE Healthcare Announces Next-Generation Small Cyclotron and PET Tracer Production Solution to Enable Increased Access to PET Imaging

Baltimore, Maryland – June 7, 2015 –Tracers for Positron Emission Tomography (PET) imaging procedures play a critical role in medical care today. Yet the logistics of getting tracers onsite at healthcare providers’ facilities can sometimes prove difficult for sites outside of radiopharmacies’ distribution network, particularly in emerging markets. GE Healthcare (NYSE:GE) announced today that it... Read more

Healthcare challenges meet promising opportunities: GE Healthcare offers more outcome-driven solutions to support quality care

Denver, CO – June 6, 2015 – Healthcare systems’ operational costs continue to spiral out of control, increasing in all aspects of the organization. With a rapidly changing industry environment and evolving patient populations, GE Healthcare, a division of General Electric Company (NYSE: GE), is showcasing a suite of new and enhanced offerings at the... Read more

GE Healthcare to expand IT Centre of Excellence in Szeged, Hungary

Szeged, Hungary – 02 June, 2015- GE Healthcare today announced that it is to expand its Healthcare IT Centre of Excellence in Szeged, Hungary.   At an event attended by Vice-Rector of the University of Szeged, Professor Lajos Kemény, and Deputy Mayor of Szeged, Mr. http://www.genewsroom.com/press-releases/ge-healthcare-expand-it-centre-excellence-szeged-hungary-280734 Read more

In-Field Upgrades for GE Healthcare 1.5T MRI Systems with SIGNA Explorer Lift Designed to Help Save up to 50 Percent on Replacement Costs

Waukesha, WI – May 20, 2015 –GE Healthcare introduced a new in-field upgrade program^ for 1.5T magnetic resonance imaging (MRI) systems in most regions globally. http://www.genewsroom.com/press-releases/field-upgrades-ge-healthcare-15t-mri-systems-signa-explorer-lift-designed-help-save Read more

Using Isosmolar contrast agent during angioplasty reduces risk of renal and cardiac events, say data from GE Healthcare supported study

Paris, May 19, 2015 – Significantly fewer renal and cardiac events are associated with angioplasty procedures using isosmolar contrast medium (IOCM) agent Visipaque™ (iodixanol) than those using low-osmolar contrast media (LOCM), demonstrate data from abstracts presented today at the EuroPCR Congress 2015 in Paris.    http://www.genewsroom.com/press-releases/using-isosmolar-contrast-agent-during-angioplasty-reduces-risk-renal-and-cardiac Read more

Assessing Risk, Expanding Reach: Innovative Ultrasound Designed For Front-Line Healthcare Workers to Help Improve Maternal Health

GENEVA, SWITZERLAND- May 19, 2015 – GE Healthcare introduced today in certain countries in Africa and Southeast Asia its new Vscan AccessTM portable ultrasound system, designed to help healthcare providers improve care. http://www.genewsroom.com/press-releases/assessing-risk-expanding-reach-innovative-ultrasound-designed-front-line-healthcare Read more

New JEOL E-Beam Lithography System to Enhance Quantum NanoFab Capabilities

FOR IMMEDIATE RELEASE CONTACT:Patricia Corkum, Marketing Manager978-536-2273 • pcorkum@jeol.com • www.jeolusa.com May 5, 2015 – Peabody, MA — A state-of-the-art JEOL e-beam lithography system will soon be a new resource for quantum information science researchers that utilize the cutting-edge facilities at the University of Waterloo Quantum NanoFab in Waterloo, Ontario. The JEOL JBX-6300FS e-beam system will... Read more

Pacific Biosciences Achieves Second Development Milestone in Clinical Diagnostics Agreement With Roche

MENLO PARK, Calif., May 5, 2015 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), provider of the PacBio® RS II Sequencing System, today announced that it has achieved a second development milestone under its development, commercialization and license agreement with F. Hoffman-La Roche Ltd (Roche), earning an additional $10 million.The development, commercialization and license... Read more

Pacific Biosciences and RainDance Technologies Partner to Co-Develop and Commercialize Novel Solution For de novo Whole Genome Assembly

MENLO PARK, Calif. and BILLERICA, Mass., May 5, 2015 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), provider of the PacBio® RS II Sequencing System, and RainDance Technologies, Inc., a genomics tools company dedicated to simplifying the analysis of complex genetic diseases, today announced their entry into a co-development and co-marketing agreement to commercialize... Read more